Literature DB >> 26164839

Consensus diagnostic histopathological criteria for acute gastrointestinal graft versus host disease improve interobserver reproducibility.

Andreas Kreft1, Anja Mottok, Ildiko Mesteri, Diana M Cardona, Anne Janin, Anja A Kühl, Mindaugas Andrulis, Andrea Brunner, Howard M Shulman, Giovanni Negri, Alexandar Tzankov, Elisabeth Huber.   

Abstract

Graft versus host disease (GvHD) is a clinically important complication after allogeneic hematopoietic stem cell transplantation (HSCT). Its diagnosis relies on clinical and histopathological findings. In order to evaluate and improve inter-institutional diagnostic agreement on histological diagnosis and grading of acute gastrointestinal GvHD, we conducted a round robin test, which included 33 biopsies from 23 patients after HSCT. Five pathologists from different institutions independently evaluated the original sections from the biopsies submitted for diagnosis. Based on their results, consensus qualitative criteria for the assessment of typical histological features of GvHD (e.g., apoptosis, crypt destruction, mucosa denudation) were proposed, including detailed descriptions as well as histological images. In a second round robin test with involvement of the same pathologists, the reproducibility of both diagnosis and grading had improved. Remaining differences were mostly related to differential diagnostic considerations, including viral infection or toxic side effects of medication, which should be resolved by integrating histopathological findings with proper clinical information.

Entities:  

Mesh:

Year:  2015        PMID: 26164839     DOI: 10.1007/s00428-015-1803-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  22 in total

1.  Histological spectrum of mycophenolate mofetil-related colitis: association with apoptosis.

Authors:  George Liapis; John Boletis; Chrysanthi Skalioti; George Bamias; Katerina Tsimaratou; Efstratios Patsouris; Ioanna Delladetsima
Journal:  Histopathology       Date:  2013-09-11       Impact factor: 5.087

2.  NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

Authors:  Howard M Shulman; Diana M Cardona; Joel K Greenson; Sangeeta Hingorani; Thomas Horn; Elisabeth Huber; Andreas Kreft; Thomas Longerich; Thomas Morton; David Myerson; Victor G Prieto; Avi Rosenberg; Nathaniel Treister; Kay Washington; Mirjana Ziemer; Steven Z Pavletic; Stephanie J Lee; Mary E D Flowers; Kirk R Schultz; Madan Jagasia; Paul J Martin; Georgia B Vogelsang; David E Kleiner
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-29       Impact factor: 5.742

3.  Gastric graft-versus-host disease: a blinded histologic study.

Authors:  K Washington; R C Bentley; A Green; J Olson; W R Treem; H R Krigman
Journal:  Am J Surg Pathol       Date:  1997-09       Impact factor: 6.394

4.  Histopathological diagnosis of graft-versus-host disease of the skin: an interobserver comparison.

Authors:  M Ziemer; P Haeusermann; A Janin; D Massi; M Ziepert; D Wolff; H Greinix; U Hillen
Journal:  J Eur Acad Dermatol Venereol       Date:  2013-08-01       Impact factor: 6.166

5.  Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.

Authors:  Joshua Melson; Shriram Jakate; Henry Fung; Sally Arai; Ali Keshavarzian
Journal:  Am J Hematol       Date:  2007-10       Impact factor: 10.047

6.  The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients.

Authors:  R J Epstein; G B McDonald; G E Sale; H M Shulman; E D Thomas
Journal:  Gastroenterology       Date:  1980-04       Impact factor: 22.682

Review 7.  Cytomegalovirus infection after bone marrow transplantation in children.

Authors:  Elio Castagnola; Barbara Cappelli; Daniela Erba; Anna Rabagliati; Edoardo Lanino; Giorgio Dini
Journal:  Hum Immunol       Date:  2004-05       Impact factor: 2.850

8.  Clinical severity scores in gastrointestinal graft-versus-host disease.

Authors:  Julie Abraham; Anne Janin; Jean-Marc Gornet; Régis Peffault de Latour; Marie Robin; Aliénor Xhaard; Flore Sicre de Fontebrune; Jean Yves Mary; Matthieu Allez; Raphael Porcher; Gérard Socié
Journal:  Transplantation       Date:  2014-05-15       Impact factor: 4.939

9.  A comparison of Cohen's Kappa and Gwet's AC1 when calculating inter-rater reliability coefficients: a study conducted with personality disorder samples.

Authors:  Nahathai Wongpakaran; Tinakon Wongpakaran; Danny Wedding; Kilem L Gwet
Journal:  BMC Med Res Methodol       Date:  2013-04-29       Impact factor: 4.615

10.  Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients.

Authors:  W Kreisel; M Dahlberg; H Bertz; J Harder; K Potthoff; P Deibert; A Schmitt-Graeff; J Finke
Journal:  Bone Marrow Transplant       Date:  2011-06-27       Impact factor: 5.483

View more
  9 in total

1.  Graft-versus-Host Disease of the Gut: A Histologic Activity Grading System and Validation.

Authors:  David Myerson; Gideon Steinbach; Ted A Gooley; Howard M Shulman
Journal:  Biol Blood Marrow Transplant       Date:  2017-05-19       Impact factor: 5.742

Review 2.  Current approach to early gastrointestinal and liver complications of hematopoietic stem cell transplantation.

Authors:  Erden Atilla; Pınar Ataca Atilla; Güldane Cengiz Seval; Mehmet Bektaş; Taner Demirer
Journal:  Turk J Gastroenterol       Date:  2019-02       Impact factor: 1.852

3.  Use of the National Institutes of Health Consensus Guidelines Improves the Diagnostic Sensitivity of Gastrointestinal Graft-Versus-Host Disease.

Authors:  Diana M Cardona; Claire J Detweiler; Michael J Shealy; Anthony D Sung; Daniel M Wild; Martin H Poleski; Bryan L Balmadrid; Constance T Cirrincione; David N Howell; Keith M Sullivan
Journal:  Arch Pathol Lab Med       Date:  2018-04-26       Impact factor: 5.534

Review 4.  Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence.

Authors:  Adam Kuba; Ludek Raida
Journal:  Mediators Inflamm       Date:  2018-03-26       Impact factor: 4.711

5.  An investigation of the diagnostic, predictive, and prognostic impacts of three colonic biopsy grading systems for acute graft versus host disease.

Authors:  Andreas Kreft; Katrin Hippe; Eva Maria Wagner-Drouet; Isabelle Ries; Arne Kandulski; Maike Büttner-Herold; Helmut Neumann; Daniela Weber; Ernst Holler; Mario Schindeldecker
Journal:  PLoS One       Date:  2021-08-26       Impact factor: 3.240

6.  Parametric Imaging of Contrast-Enhanced Ultrasound (CEUS) for the Evaluation of Acute Gastrointestinal Graft-Versus-Host Disease.

Authors:  Antonia-Maria Pausch; Sylvia Kammerer; Florian Weber; Wolfgang Herr; Christian Stroszczynski; Ernst Holler; Matthias Edinger; Daniel Wolff; Daniela Weber; Ernst-Michael Jung; Tobias Wertheimer
Journal:  Cells       Date:  2021-05-03       Impact factor: 6.600

7.  A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation.

Authors:  Francisco M Marty; Drew J Winston; Roy F Chemaly; Kathleen M Mullane; Tsiporah B Shore; Genovefa A Papanicolaou; Greg Chittick; Thomas M Brundage; Chad Wilson; Marion E Morrison; Scott A Foster; W Garrett Nichols; Michael J Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2018-10-04       Impact factor: 5.742

8.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.

Authors:  Daniel Wolff; Vedran Radojcic; Robert Lafyatis; Resat Cinar; Rachel K Rosenstein; Edward W Cowen; Guang-Shing Cheng; Ajay Sheshadri; Anne Bergeron; Kirsten M Williams; Jamie L Todd; Takanori Teshima; Geoffrey D E Cuvelier; Ernst Holler; Shannon R McCurdy; Robert R Jenq; Alan M Hanash; David Jacobsohn; Bianca D Santomasso; Sandeep Jain; Yoko Ogawa; Philipp Steven; Zhonghui Katie Luo; Tina Dietrich-Ntoukas; Daniel Saban; Ervina Bilic; Olaf Penack; Linda M Griffith; Meredith Cowden; Paul J Martin; Hildegard T Greinix; Stefanie Sarantopoulos; Gerard Socie; Bruce R Blazar; Joseph Pidala; Carrie L Kitko; Daniel R Couriel; Corey Cutler; Kirk R Schultz; Steven Z Pavletic; Stephanie J Lee; Sophie Paczesny
Journal:  Transplant Cell Ther       Date:  2021-06-10

9.  Evaluation of crypt apoptotic bodies and apoptotic indices in pediatric celiac disease by routine staining and H2AX immunostaining.

Authors:  Sarah Adel Hakim; Dalia Abd El-Kareem
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.